Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Disease AIDS Clinical Trials Group. [electronic resource]
Producer: 19990729Description: 61-7 p. digitalISSN:- 0022-1899
- Acquired Immunodeficiency Syndrome -- complications
- Adult
- Antigens, CD -- analysis
- Double-Blind Method
- Esophageal Diseases -- complications
- Ethnicity
- Female
- HIV Infections -- complications
- Humans
- Male
- Placebos
- Quality of Life
- Receptors, Tumor Necrosis Factor -- analysis
- Receptors, Tumor Necrosis Factor, Type II
- Stomatitis, Aphthous -- drug therapy
- Thalidomide -- adverse effects
- Tumor Necrosis Factor-alpha -- analysis
- Ulcer -- complications
- United States
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.